Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Porter

Showing results (101-110 of 298) with videos related to

Pageof 30
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2004
Influence of physicochemical properties on the patterns of association of a series of aliphatic esters of halofantrine with plasma lipoproteinsMichelle P McIntosh, William N Charman, Michael Campbell, et al.
Behavioural Pharmacology|September 20, 2005
Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination taskA J Prus, S D Philibin, A L Pehrson, et al.
Physiology & Behavior|January 1, 1987
Exposure to magnetic resonance imaging does not produce taste aversion in ratsJ M Messmer, J H Porter, P Fatouros, et al.
Molecular Pharmaceutics|March 17, 2021
Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and PermeabilityYusuke Tanaka, Tri-Hung Nguyen, Estelle J A Suys, et al.
Molecular Pharmaceutics|January 19, 2012
Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulationLisa M Kaminskas, Victoria M McLeod, Christopher J H Porter, et al.
Journal of Pharmaceutical Sciences|February 15, 2003
Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugsGreg A Kossena, Ben J Boyd, Christopher J H Porter, et al.
Advanced Drug Delivery Reviews|December 25, 2007
Enhancing intestinal drug solubilisation using lipid-based delivery systemsChristopher J H Porter, Colin W Pouton, Jean F Cuine, et al.
Pharmaceutical Research|March 23, 2004
Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulationsAnn Marie Kaukonen, Ben J Boyd, Christopher J H Porter, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 24, 2004
A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugsGreg A Kossena, William N Charman, Ben J Boyd, et al.
Journal of Pharmaceutical Sciences|July 2, 2011
Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearanceLisa M Kaminskas, Victoria M McLeod, Christopher J H Porter, et al.
Pageof 30

Showing results (101-110 of 298) with videos related to

Sort By:
Pageof 30
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2004
Influence of physicochemical properties on the patterns of association of a series of aliphatic esters of halofantrine with plasma lipoproteinsMichelle P McIntosh, William N Charman, Michael Campbell, et al.
Behavioural Pharmacology|September 20, 2005
Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination taskA J Prus, S D Philibin, A L Pehrson, et al.
Physiology & Behavior|January 1, 1987
Exposure to magnetic resonance imaging does not produce taste aversion in ratsJ M Messmer, J H Porter, P Fatouros, et al.
Molecular Pharmaceutics|March 17, 2021
Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and PermeabilityYusuke Tanaka, Tri-Hung Nguyen, Estelle J A Suys, et al.
Molecular Pharmaceutics|January 19, 2012
Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulationLisa M Kaminskas, Victoria M McLeod, Christopher J H Porter, et al.
Journal of Pharmaceutical Sciences|February 15, 2003
Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugsGreg A Kossena, Ben J Boyd, Christopher J H Porter, et al.
Advanced Drug Delivery Reviews|December 25, 2007
Enhancing intestinal drug solubilisation using lipid-based delivery systemsChristopher J H Porter, Colin W Pouton, Jean F Cuine, et al.
Pharmaceutical Research|March 23, 2004
Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulationsAnn Marie Kaukonen, Ben J Boyd, Christopher J H Porter, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 24, 2004
A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugsGreg A Kossena, William N Charman, Ben J Boyd, et al.
Journal of Pharmaceutical Sciences|July 2, 2011
Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearanceLisa M Kaminskas, Victoria M McLeod, Christopher J H Porter, et al.
Pageof 30